**Core tip:** The feasibility and safety of the laparoscopic approach in overweight (OW) patients and cases of total gastrectomy were already reported, but an assessment of the feasibility and safety of laparoscopic total gastrectomy (LTG) in OW patients has not yet been conducted. In the article we performed two main analyses. One is a comparison of postoperative outcomes after LTG between OW and non-OW patients. The other is that after open total gastrectomy. In order to balance the baseline characteristics between laparoscopy and open groups, we performed propensity score matching. We found out two main results through the analyses. One is LTG in OW patients is feasible and safe although it remains technically challenging (longer operation time). The other is OW has less impact on laparoscopic versus open approach.

INTRODUCTION
============

Over the past few decades, the proportion of proximal gastric cancer among all gastric cancer cases has been increasing\[[@B1],[@B2]\]. The standard treatment for proximal gastric cancer is total gastrectomy with adequate lymph node dissection, while the laparoscopic approach is also applied in some high-volume institutions\[[@B3],[@B4]\]. Meanwhile, overweight (OW) is an important health issue worldwide, and the number of OW patients in Japan is also increasing\[[@B5]\]. Consequently, the number of laparoscopic total gastrectomy (LTG) procedures performed in OW patients is increasing.

OW is a risk factor for postoperative complications in gastrectomy because of the narrow and deep operative field, increased risk of friable tissues, and increased frequency of comorbidities\[[@B6],[@B7]\]. While some previous studies reported on the feasibility of laparoscopic gastrectomy in OW patients, other articles showed that OW has a negative impact on laparoscopic gastrectomy, and this approach in OW patients remains technically challenging\[[@B8]-[@B11]\]. Total gastrectomy is also a demanding laparoscopic procedure in any case. Due to the difficulty of lymph node dissection and reconstruction, LTG procedures have yet to be standardized. Total gastrectomy and OW seems among the worst combinations for the laparoscopic approach. However, whether OW really has a worse impact on LTG compared to open total gastrectomy (OTG) remains unknown. Thus, in the present study, we focused on the differences in LTG postoperative outcomes between OW and non-OW patients. We also analyzed these results in the OTG group to evaluate the impact of OW on LTG versus OTG.

MATERIALS AND METHODS
=====================

Patients and data collection
----------------------------

Between January 1999 and July 2016, 395 patients underwent total gastrectomy in the Department of Gastric Surgery, Tokyo Medical and Dental University Hospital, Tokyo, Japan. Patients with non-adenocarcinoma (*n* = 18), with combined surgery (*n* = 23), who received thoracotomy approach (*n* = 25), or for whom incomplete data were available (*n* = 8), were excluded; ultimately, 321 patients were enrolled in the present study. The following information was collected for each patient: age, sex, body mass index (BMI), operation period (early: 1999-2008, late: 2009-2016), pStage, tumor size, extent of lymph node dissection, presence or absence of splenectomy, operative time, intraoperative blood loss, number of retrieved lymph nodes, morbidity rate, and length of postoperative hospital stay.

Propensity score matching and definition of OB and non-OB groups
----------------------------------------------------------------

The following variables were selected for propensity score matching: gender, age, operation period, extent of lymph node dissection, splenectomy, pT and, pN. The score was estimated using a logistic regression model and propensity-score-matched pairs without replacement (1:1 match with a caliper of width 0.1 standard deviations) were created.

After matching, both LTG and OTG group consisted of 76 patients for the analyses. Both groups were then divided into non-OW and OW groups (Figure [1](#F1){ref-type="fig"}). BMI was used to define OW. Patients with a BMI ≥ 25 were classified into the OW group, while those with a BMI \< 25 were classified into the non-OW group.

![Flow chart of patient enrollment.](WJCC-6-1094-g001){#F1}

Staging and operative procedure
-------------------------------

Stages were classified according to the 7^th^ edition of the Union for International Cancer Control classification system. Lymph node dissection was performed according to the guidelines of Japanese Gastric Cancer Association at the time of surgery\[[@B12],[@B13]\]. In principle, the LTG approach was applied only in clinical Stage I patients. If clinical Stage II or III patients wished to undergo LTG, we performed it after offering a sufficient explanation and obtaining informed consent from the patients and their family members. A laparoscopic splenectomy was not performed unless the tumor was located at the greater curvature. In the LTG and OTG groups, Roux-en-Y reconstruction using a circular stapler was performed in all patients. In LTG, a laparoscopy-specific purse-string suturing device (END-PSD) was used to perform purse-string suturing and subsequent anvil insertion into the esophagus\[[@B14]\].

Definition and classification of complications
----------------------------------------------

Complications were graded according to Clavien-Dindo classification\[[@B15]\]. All complications Grade I-V were counted complications, while those Grade IIIa or higher were considered severe complications.

Statistical analysis
--------------------

Categorical values were analyzed using the chi-squared or Fischer's exact analysis. Continuous values are shown as median and ranges. Normally distributed data were analyzed using independent *t*-tests, while non-normally distributed data were analyzed using the Mann-Whitney test. Overall survival (OS) was defined as the interval from surgery to death of any cause. Kaplan-Meier curves were used to compare prognoses between the non-OW and OW groups within the LTG and OTG groups. *P* values \< 0.05 were considered statistically significant for all analyses. Statistical analyses were performed using SPSS version 19.0 software (IBM SPSS, Chicago, IL, United States).

RESULTS
=======

Baseline characteristics and perioperative results of the enrolled population
-----------------------------------------------------------------------------

Baseline characteristics are shown in Table [1](#T1){ref-type="table"}. Before matching, in the OTG group versus the LTG group, more operations were performed in early period, D2 lymph node dissection and splenectomy were performed more frequently, mean tumor size was larger, tumor depth and lymph node classification were higher, and pStage were more advanced. After matching, baseline characteristics were comparable between both groups.

###### 

Baseline characteristics of enrolled patients

                                    **All patients**   **Matched patients**                                                                      
  --------------------------------- ------------------ ---------------------- ------------------ --------- ------------------ ------------------ ------
  Gender                            Male               81                     162                0.53      55                 62                 0.18
  Female                            29                 78                                        21        14                                    
  Age (median, range)                                  70 (32-83)             69 (17-86)         0.92      70 (32-83)         71 (17-86)         0.53
  BMI (kg/m^2^) (median, range)                        23.2 (15.8-31.0)       22.2 (13.6-38.3)   0.07      21.9 (15.8-30.4)   27.4 (13.6-35.4)   0.35
  period                            Early              39                     148                \< 0.01   39                 28                 0.07
  Late                              71                 63                                        37        48                                    
  Extent of lymph node dissection   D2 \<              91                     120                \< 0.01   57                 53                 0.47
  D2                                22                 142                                       19        23                                    
  Splenectomy                       Yes                14                     99                 \< 0.01   14                 19                 0.33
  No                                96                 112                                       62        57                                    
  Tumor size (mm) (median, range)                      45 (6-200)             70 (13-230)        \< 0.01   52 (6-200)         59 (14-213)        0.14
  pT                                M                  21                     7                  \< 0.01   9                  6                  0.49
  SM                                34                 23                                        21        17                                    
  MP                                19                 15                                        11        8                                     
  SS                                20                 71                                        19        20                                    
  SE                                16                 89                                        16        22                                    
  SI                                0                  5                                         0         2                                     
  pN                                N0                 65                     63                 \< 0.01   38                 36                 0.38
  N1                                19                 30                                        13        7                                     
  N2                                13                 40                                        12        12                                    
  N3a                               9                  48                                        9         12                                    
  N3b                               4                  30                                        4         9                                     
  pStage                            I                  66                     37                 \< 0.01   35                 32                 0.20
  II                                20                 51                                        17        9                                     
  III                               19                 93                                        19        27                                    
  IV                                5                  30                                        5         8                                     

OTG: Open total gastrectomy; LTG: Laparoscopic total gastrectomy; BMI: Body mass index.

Comparison of non-OW and OW patient baseline characteristics in the LTG and OTG groups
--------------------------------------------------------------------------------------

A comparison of the baseline characteristics of non-OW and OW patients in the LTG and OTG groups is shown in Table [2](#T2){ref-type="table"}. Aside from the statistical difference in BMI in the LTG and OTG groups, all variables such as gender, age, extent of lymph node dissection, splenectomy, tumor size, tumor depth, lymph node classification, and pStage were comparable between non-OW and OW patients in the LTG and OTG groups.

###### 

Baseline characteristics of non-overweight and overweight groups in both laparoscopy and open groups

                                    **LTG (*n* = 76)**   **OTG (*n* = 76)**                                                                      
  --------------------------------- -------------------- -------------------- ------------------ --------- ------------------ ------------------ ---------
  Gender                            Male                 42                   13                 0.66      52                 10                 0.45
  Female                            15                   6                                       11        3                                     
  Age (median, range)                                    70 (40-83)           64 (32-79)         0.06      72 (17-80.6)       71 (29-79)         0.73
  BMI (median, range)                                    21.2 (15.8-24.8)     26.6 (25.2-30.4)   \< 0.01   20.9 (13.6-24.9)   27.6 (25.0-35.4)   \< 0.01
  Extent of lymph node dissection   \< D2                42                   15                 0.42      42                 11                 0.17
  D2 ≤                              15                   4                                       21        2                                     
  Splenectomy                       Yes                  11                   3                  0.73      17                 2                  0.31
  No                                46                   16                                      46        11                                    
  Tumor size (mm) (median, range)                        56 (6-185)           50 (7-200)         0.43      53 (14-211)        75 (25-210)        0.25
  Depth of tumor                    M                    7                    2                  0.11      6                  0                  0.37
  SM                                15                   6                                       12        5                                     
  MP                                5                    6                                       7         1                                     
  SS                                16                   3                                       18        2                                     
  SE                                14                   2                                       18        4                                     
  SI                                0                    0                                       1         1                                     
  Lymph node classification         N0                   26                   12                 0.43      30                 6                  0.85
  N1                                9                    4                                       6         1                                     
  N2                                10                   2                                       9         3                                     
  N3a                               8                    1                                       11        1                                     
  N3b                               4                    0                                       7         2                                     
  pStage                            I                    25                   10                 0.34      26                 6                  0.51
  II                                11                   6                                       9         0                                     
  III                               17                   2                                       22        5                                     
  IV                                4                    1                                       6         2                                     

OTG: Open total gastrectomy; LTG: Laparoscopic total gastrectomy; BMI: Body mass index; non-OW: Non-overweight group; OW: Overweight group.

Comparison of perioperative results between non-OW and OW in LTG and OTG groups
-------------------------------------------------------------------------------

The non-OW and OW patients' perioperative results were compared in the LTG and OTG groups (Table [3](#T3){ref-type="table"}). In the LTG group, although operative time was longer (*P* \< 0.01), overall, local, and systemic complication rates were comparable between non-OW and OW patients (*P* = 0.49, 0.14, and 0.56, respectively).

###### 

Perioperative results of non-overweight and overweight groups in both open and laparoscopy groups

                                                             **LTG (*n* = 76)**   **OTG (*n* = 76)**                                                             
  ---------------------------------------------------------- -------------------- -------------------- ---------- --------------- ---------------- ------------- ------
  Operative time (min) (median, range)                       332 (209-541)        400 (230-520)        0.01       265 (134-810)   276 (195-460)    0.32          
  Estimated intraoperative blood loss (mL) (median, range)   188 (0-2492)         202 (0-1714)         0.63       445 (90-3406)   780 (104-1980)   0.14          
  No. of retrieved lymph nodes (median, range)               43 (8-71)            36 (14-117)          0.4        41 (9-89)       29 (2-49)        0.03          
  Morbidity (%)                                              Overall              13 (23)              5 (26)     0.49            23 (37)          8 (62)        0.1
                                                             Local                7 (12)               5 (26)     0.14            14 (22)          7 (54)        0.03
  Systemic                                                   8 (14)               3 (16)               0.56       13 (21)         4 (31)           0.32          
  Severe                                                     5 (9)                3 (11)               0.56       8 (13)          4 (31)           0.12          
  Anastomotic Leakage                                        3 (5)                3 (16)               0.16       2 (3)           3 (23)           0.03          
  Anastomotic stricture                                      1 (2)                1 (5)                0.44       1 (2)           1 (8)            0.32          
  Pancreatic fistula                                         3 (5)                0 (0)                0.42       3 (5)           2 (15)           0.2           
  Abdominal abscess                                          2 (4)                0 (0)                0.56       3 (5)           2 (15)           0.2           
  pulmonary                                                  5 (9)                2 (11)               0.90       9 (14)          1 (8)            0.46          
  Wound infection                                            1 (2)                1 (5)                0.44       3 (5)           2 (15)           0.2           
  POH (d) (median, range)                                                         9 (6-74)             9 (6-73)   0.75            14 (7-159)       19 (10-145)   0.1

OTG: Open total gastrectomy; LTG: Laparoscopic total gastrectomy; BMI: Body mass index; non-OW: Non-overweight group; OW: Overweight group; POH: Postoperative hospital stay.

On the other hand, in the OTG group, although operative time and estimated blood loss were comparable between non-OW and OW patients, the number of retrieved lymph nodes was less (*P* = 0.03), local complication rate was higher (*P* = 0.03) and anastomotic leakage was more frequent in OW patients (*P* = 0.03).

Comparison of OS between non-OB and OB patients in the LTG and OTG groups
-------------------------------------------------------------------------

The Kaplan-Meyer curves were depicted using log-rank tests in Figure [2](#F2){ref-type="fig"}. The mean follow-up period was 56 mo (range, 1-156 mo). In the LTG (Figure [2A](#F2){ref-type="fig"}) and OTG (Figure [2B](#F2){ref-type="fig"}) groups, there was no survival difference between non-OW and OW patients (*P* = 0.66 and 0.18, respectively).

![Kaplan-Meier curves for overall survival in the laparoscopic total gastrectomy (A) and open total gastrectomy (B) groups. OW: Overweight.](WJCC-6-1094-g002){#F2}

DISCUSSION
==========

In the present study, median operative time was significantly longer, but morbidity rates were similar in OW patients than in non-OW patients in the LTG group. OS was also comparable between OW and non-OW patients in the LTG group.

OW and total gastrectomy are the factors that make surgeons reluctant to choose the laparoscopic approach due to technical difficulty. Both major drawbacks were addressed in the present study. The feasibility and safety of the laparoscopic approach in OW patients and cases of total gastrectomy were already reported\[[@B9]-[@B11],[@B16]-[@B18]\], but an assessment of the feasibility and safety of LTG in OW patients has not yet been conducted.

Some articles reported the feasibility of laparoscopic distal gastrectomy in OW patients\[[@B9]-[@B11]\]. The present results add further evidence of the feasibility and safety of LTG in OW patients, although operative time was longer than that in non-OW patients.

Another implication of the present study's findings is that OW might have a lesser impact in LTG than in OTG. The reasons for this are intriguing. In laparoscopic surgery, a meticulous procedure can be performed through a magnified view. Pneumoperitoneum might be another factor that can contribute to less blood loss from the adipose tissue and small vessels.

Shimada et al\[[@B9]\] reported that the long-term outcomes of OW patients were worse after laparoscopic distal gastrectomy and discussed that restricted lymph node dissection might be the cause. In the present study, long-term outcomes were comparable between OW and non-OW patients in the LTG group. The numbers of retrieved lymph nodes were comparable between OW and non-OW patients in the LTG group, so this might be the reason for minimizing the stage migration and also the curative effect of lymph node dissection in the present study. On the other hand, the number of retrieved lymph nodes was less in OW patients in the OTG group. Although there was no difference in the OS between OW and non-OW patients, it was implied that OW might have a greater impact for lymph node dissection in open approach.

There are two limitations of the present study. First, it was a retrospective study although the dataset was prospectively collected. Second, the number of cases was not large enough for conclusive results because propensity score matching was conducted to balance the baseline characteristics of the LTG and the OTG groups in the present study.

In conclusion, LTG in OW patients remains technically challenging but can be performed safely. Our findings also imply that OW had a lesser effect on LTG than OTG.

ARTICLE HIGHLIGHTS
==================

Research background
-------------------

While the proportion of gastric cancer in upper third stomach is increasing, increased number of overweight (OW) patients is an important health issue. Consequently, laparoscopic total gastrectomy (LTG) to OW patients is increasing.

Research motivation
-------------------

Total gastrectomy and OW seems among the worst combinations for the laparoscopic approach. However, whether OW really has a worse impact on LTG compared to open total gastrectomy remains unknown.

Research objectives
-------------------

The main objectives of this retrospective study were to investigate safety and oncological feasibility of LTG in OW patients.

Research methods
----------------

Propensity score matching selected 152 patients (76 laparoscopic, 76 open), from 321 patients who underwent total gastrectomy from 1999 to 2016. The patients were subsequently divided into the OW (≥ 25) or non-OW (\< 25) group by body mass index. Postoperative outcomes of laparoscopic versus open approaches were compared between OW and non-OW groups.

Research results
----------------

In the laparoscopy group, operative time was longer (*P* = 0.01) in the OW group, however, other perioperative results were comparable between the non-OW and OW groups. In the open group, number of retrieved lymph nodes were less (*P* = 0.03) and local complication rate was more frequent (*P* = 0.03) in the OW group.

Research conclusions
--------------------

LTG in OW patients remains technically challenging but can be performed safely. Our findings imply that OW has a lesser effect on the laparoscopic versus open approach to total gastrectomy.

Research perspectives
---------------------

Laparoscopic approach can be a choice for total gastrectomy in OW patients in experienced institutions.
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